Every specialty drug cost and rebate is tied back to the individual claim, giving employers the visibility to make informed benefit design decisions
For people with type 2 diabetes, lower BMI thresholds may apply (30 kg/m) as outlined in NICE guidance
CAT Number: I042736 CAS Number: 2381089-83-2 Molecular Formula: C221H342N46O68 Molecular Weight: 4731.33 Purity: 95% Inquiry Now Details Technical Specifications Inquiry RetatrutideCat No.:I042736is an investigational peptide-based drug that acts as a dual agonist of the GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory polypeptide) receptors
The drugs can also reduce the effectiveness of some forms of birth control, making unplanned pregnancies more likely
Report Scope Regional Analysis How Big is the North America GLP-1 Receptor Agonist Market Size
For semaglutide, the brand name varies depending on whether the medication is administered orally or by injection, and whether it is licensed for diabetes management or weight management